1. LB0001 Baricitinib, an Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and An Inadequate Response to CDMARD Therapy: Results of the Phase 3 RA-Build Study. (9th June 2015) Authors: Dougados, M.; van der Heijde, D.; Chen, Y.-C.; Greenwald, M.; Drescher, E.; Liu, J.; Beattie, S.; de la Torre, I.; Rooney, T.; Schlichting, D.; de Bono, S.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies. (15th July 2016) Authors: Weinblatt, M.; Taylor, P.; Tanaka, Y.; Keystone, E.; Schiff, M.; Fleischmann, R.; Yang, L.; Arora, V.; de Bono, S.; Holzkaemper, T.; Schlichting, D.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0198 Baricitinib Effects on Lipid and NMR-Measured Lipoprotein Profiles in A Phase 3 Study in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Taylor, P.; Keystone, E.; Tanaka, Y.; van der Heijde, D.; Zhong, J.; Thanabalasundrum, S.; Ruotolo, G.; Schlichting, D.; Rooney, T.P.; Macias, W.L.; Zuckerman, S.; de Bono, S.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM). (15th July 2016) Authors: Tanaka, Y.; Fleischmann, R.; Schiff, M.; Takeuchi, T.; Keystone, E.; Weinblatt, M.; Zuckerman, S.; Issa, M.; Thanabalasundrum, S.; Augendre-Ferrante, B.; de Bono, S.; Schlichting, D.; Rooney, T.P.; Macias, W.L.; Taylor, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0609 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy. (15th July 2016) Authors: Keystone, E.; Taylor, P.; Tanaka, Y.; Gaich, C.; DeLozier, A.M.; Dudek, A.; Velasco Zamora, J.; Covarrubias Cobos, J.; de Bono, S.; Arora, V.; Yang, L.; Linetzky, B.; Weinblatt, M.E. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0617 Work Productivity and Daily Activity in Patients with Rheumatoid Arthritis in Four Phase III Randomized Clinical Trials of Baricitinib. (15th July 2016) Authors: Smolen, J.S.; DeLozier, A.M.; de Bono, S.; Yang, L.; Gaich, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗